Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids - Journal of Molecular and Cellular Cardiology

September 23,2024

PDF) Epoxide hydrolase 1 (EPHX1) hydrolyzes epoxyeicosanoids and

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Innate Immune Nod1/RIP2 Signaling Is Essential for Cardiac

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Erratum to “Akt2 knockout alleviates prolonged caloric restriction

Epoxyeicosatrienoic Acid as Therapy for Diabetic and Ischemic

Epoxyeicosatrienoic acids and soluble epoxide hydrolase in

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Suppression of inflammation and fibrosis using soluble epoxide

Therapeutic and Prognostic Significance of Arachidonic Acid in

Inhibition of soluble epoxide hydrolase alleviates insulin

Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects

Discovery of Novel Soluble Epoxide Hydrolase Inhibitors as Potent

Epoxyeicosatrienoic acids and soluble epoxide hydrolase in